Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma

NCT03030261 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma in Relapse

Interventions

DRUG: Elotuzumab
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Washington University School of Medicine

Collaborators

Bristol-Myers Squibb
Celgene